On March 4, 2021, our Chinese customer Yangtze River Pharmaceutical (Group) Co., Ltd. became one of 12 organizations to win the EFQM Global Award, one of the three major quality awards in the world. Its objective is to recognize outstanding organizations worldwide that demonstrate an indisputable track record of success in turning strategy into action and the continuous improvement of their performance. Moreover, Yangtze River Pharmaceutical Group is the first pharmaceutical company in the world to receive the award after the implementation of the new EFQM model in 2019. “This award is the result of our continuous learning, organizational changes and performance improvement, indicating that the company's management level has been aligned with the management level of world-class companies,” says Xu Jingren, chairman of Yangtze River Pharmaceutical Group.
The company, which is also celebrating its 50th anniversary this year, has grown to become the largest drug manufacturer in China with more than 16,000 employees. Its focus in on both R&D and the production of traditional Chinese and chemical medicines. In parallel to expanding its international market activities, Yangtze River Pharmaceutical Group has continuously extended its business scope, involving biological drugs, medical equipment, and health food. Among the equipment that contributes to this success is a substantial number from Syntegon.